AHA Scientific Sessions 2026 Abstract · Nov 2, 2026

Clinical Impact of Methamphetamine Use in TTN-Related Cardiomyopathy

By Coderre R, Swain W, Castrichini M et al.

Background: Truncating variants in TTN -encoded titin (TTNtvs) are the most common genetic cause of dilated cardiomyopathy (DCM). Although age, male sex, cardiovascular comorbidities, and prolonged exposure to cardiotoxic agents such as alcohol are associated with disease expressivity, the full impact of environmental exposures remains unclear. Methamphetamine use has been linked to myocardial dysfunction, but its influence on TTNtv penetrance and expressivity is not well characterized. As such, we sought to evaluate the association of methamphetamine exposure with cardiomyopathy phenotype, age at diagnosis, arrhythmic events, and cardiac mortality in a large single-center cohort of TTNtv-positive patients. Methods: Retrospective review of 1,712 ACM/DCM patients was used to identify those with a pathogenic/likely pathogenic (P/LP) TTNtv. Clinical characteristics, cardiomyopathy phenotype, arrhythmic outcomes, advanced heart failure therapies, and cardiac mortality were compared between TTNtv carriers with and without documented methamphetamine exposure. Result: Overall, 337/1,712 (20%) of ACM/DCM patients were P/LP TTNtv-positive (46% female; mean age 53±18 years, mean LVEF 48±13%). Among TTNtv-positive patients, 11/337 reported methamphetamine use. DCM was present in 90.9% of TTNtv-positive methamphetamine users compared with 51.2% of non-users (OR 9.52, p=0.012). Furthermore, TTNv-positive methamphetamine-users were diagnosed nearly 9 years earlier than non-users (37.7±7.9 vs 46.6±14.5 years; mean difference 8.9 years, 95% CI 3.0-14.8 years; p=0.006). In multivariable Firth penalized logistic regression adjusting for age at diagnosis, sex, and alcohol use, methamphetamine exposure remained associated with increased odds of DCM (adjusted OR 4.06, 95% CI 0.82-40.05, p=0.090). Methamphetamine exposure was associated with numerically higher rates of sustained ventricular tachycardia (9.1% vs 6.4%; OR 1.45, p=0.530), appropriate ICD shock (18.2% vs 7.4%; OR 2.78, p=0.205), sudden cardiac arrest (9.1% vs 2.5%; OR 3.94, p=0.261), and composite major adverse cardiomyopathy events (36.4% vs 18.1%; OR 2.58, p=0.130) but these differences did not reach statistical significance. Cardiac death occurred more frequently among methamphetamine-exposed than non-exposed (27.3% vs 2.5%; OR 14.54, 95% CI 2.10-77.72, p=0.004). Conclusion: Among TTNtv-positive patients, methamphetamine exposure was associated with a higher prevalence of DCM and significantly younger age at presentation. These findings support the hypothesis that methamphetamine exposure may act as an environmental second hit that may contribute to earlier and worse phenotypic expression of TTN-related cardiomyopathy and warrants validation and further exploration in larger multicenter cohorts.

doi.org/10.1161/circ.154.suppl_1.14602Populations

AgingResearch.News